| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |